Protective effect of recombinant human brain natriuretic peptide against contrast-induced nephropathy in elderly acute myocardial infarction patients: A randomized controlled trial

BACKGROUND: Increasing reports have demonstrated that recombinant human brain natriuretic peptide (rhBNP) can improve acute myocardial infarction (AMI) and heart failure. However, whether it can improve renal function and decrease the risk of contrast-induced nephropathy (CIN) in elderly AMI patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yi-Jing, Yin, Lin, Li, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Randomized Controlled Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9724537/
https://www.ncbi.nlm.nih.gov/pubmed/36483837
http://dx.doi.org/10.12998/wjcc.v10.i33.12221

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9724537/
https://www.ncbi.nlm.nih.gov/pubmed/36483837
http://dx.doi.org/10.12998/wjcc.v10.i33.12221

Ejemplares similares